RxDoctor Payments Data

Bruce Wolf

Allergy & Immunology · Nashville, TNNPI 1932191855

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,900 of the $14,557 with a category attached, or 88.6%. GSK accounts for 92.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $7,485 and has fallen 98.3% since, to $129 in 2022.

$14,557in general payments, 2019–2025

Across 78 payments — averaging $186.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$13K
  • Regeneron Healthcare Solutions, Inc.$311
  • CSL Behring$220
  • AstraZeneca$110
  • Sanofi$109
  • Lemaitre Vascular, Inc.$67
  • plus $257 from 11 others
$3,100in research payments, 2019–2025

Across 5 payments — averaging $619.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$2K
  • Novartis$1K

What the payments were for

  • Speaking & faculty fees$12,90089%
  • Food & beverage$1,62111%
  • Education$360%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,557 in reported general payments places this provider in the 80th percentile of 79 allergy & immunology providers in Tennessee.

See all allergy & immunology providers in Tennessee

Other allergy & immunology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →